Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results

March 6, 2023

https://www.globenewswire.com/news-release/2023/03/06/2620978/0/en/Verrica-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results.html

New Drug Application for VP-102 assigned PDUFA goal date of July 23, 2023

VP-102 has potential to address the approximately six million patients in the U.S. with molluscum contagiosum

Read more at globenewswire.com

Related news for (VRCA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.